ABIVAX (EPA:ABVX) | Finanzwire

Basculer en Français

10592	Companies
224614	Keywords
153326	Articles
118806	Press releases

Home
Companies
ABIVAX

PRESS RELEASE

published on 06/11/2025 at 22:00, 1 year ago

Abivax Announces Results of its June 6, 2025 Annual General Meeting
Abivax announced the results of its June 6, 2025 Annual General Meeting. Shareholders adopted all proposed resolutions including financial statements and appointments. More details on the vote results available on the Company's website

Annual General Meeting Shareholders Appointments Abivax Resolutions
PRESS RELEASE

published on 06/11/2025 at 22:00, 1 year ago

Abivax Announces Results of its June 6, 2025 Annual General Meeting
Abivax announces successful outcomes of its Annual General Meeting on June 6, 2025, including adoption of resolutions and appointments. Details on www.abivax.com

Annual General Meeting Appointments Abivax Resolutions Therapeutics
PRESS RELEASE

published on 06/11/2025 at 22:00, 1 year ago

Abivax Announces Results of its June 6, 2025 Annual General Meeting
Abivax announces successful results of its 2025 Annual General Meeting with approval of key resolutions including financial statements and board appointments

Annual General Meeting Shareholders Abivax AGM Results
BRIEF

published on 06/02/2025 at 22:05, 1 year ago

Abivax Reports Q1 2025 Financial Results

Cash Position Operating Loss R&D Expenses Q1 2025 Results Abivax Financials
PRESS RELEASE

published on 06/02/2025 at 22:00, 1 year ago

Abivax Presents First Quarter 2025 Financial Results
Abivax presents first quarter 2025 financial results, reporting operating loss increase to EUR -47.2M, R&D expenses growth, net loss of EUR -52.4M, and cash position at EUR 103.6M

Financial Results Cash Position Abivax Operating Loss R&D Expenses
BRIEF

published on 05/14/2025 at 18:05, 1 year 1 month ago

ABIVAX: Number of shares and voting rights as of April 30, 2025

Voting Rights Actions Abivax AMF Regulations Financial Transparency
BRIEF

published on 04/29/2025 at 22:10, 1 year 1 month ago

Abivax Completes Enrollment for Phase 3 Ulcerative Colitis Trials

Abivax Obefazimod Ulcerative Colitis Phase 3 Trials Clinical Enrollment
PRESS RELEASE

published on 04/29/2025 at 22:05, 1 year 1 month ago

Abivax Announces Completion of Enrollment for the Phase 3 ABTECT Trials in Patients with Moderately to Severely Active Ulcerative Colitis
Abivax completes enrollment for Phase 3 ABTECT Trials in patients with active ulcerative colitis. Top-line results expected in Q3 2025, NDA submission planned for H2 2026

Abivax Ulcerative Colitis Phase 3 ABTECT Trials NDA Submission
BRIEF

published on 04/22/2025 at 22:10, 1 year 1 month ago

Abivax: Terms of the Annual General Meeting and outlook for 2025

Biotechnology Abivax Clinical Trials Investment General Meeting 2025
BRIEF

published on 04/22/2025 at 22:05, 1 year 1 month ago

Abivax welcomes Dr. Dominik Höchli to its Board of Directors

Board Of Directors Abivax Phase 3 Immunology Dominik Höchli

Accesswire

Published on 06/18/2026 at 00:00, 8 hours 10 minutes ago

LIR Life Sciences Completes Comparative Animal Study Showing Successful Protamine-Enhanced Permeation Transport of Both Semaglutide and Tirzepatide
Published on 06/17/2026 at 23:30, 8 hours 40 minutes ago

Polaris Renewable Energy Announces Postponement of Annual Meeting of Shareholders
Published on 06/17/2026 at 22:50, 9 hours 20 minutes ago

International Battery Metals Ltd. Reports Fourth Quarter and Full Year Fiscal 2026 Financial Results
Published on 06/17/2026 at 22:30, 9 hours 40 minutes ago

Innodata Appoints Jayant Chauhan as Chief Financial Officer
Published on 06/17/2026 at 16:55, 15 hours 15 minutes ago

Snipp Interactive Named a Representative Vendor in the Gartner(R) 2026 Market Guide for Loyalty Program Vendors

View all ACCESSWIRE

EQS Group

Published on 06/18/2026 at 08:05, 4 minutes ago

Sunparl Releases First ESG Report: Showcasing ZKONG's Smart Retail Innovation and Sustainability Practices
Published on 06/18/2026 at 07:30, 40 minutes ago

tonies targets to more than double group revenue by 2030 and announces further international expansion plans at first-ever Capital Markets Day
Published on 06/18/2026 at 07:00, 1 hour 10 minutes ago

Press release: Leonteq concludes regulatory legacy matters
Published on 06/18/2026 at 07:00, 1 hour 10 minutes ago

Successful virtual Annual General Meeting: Ringmetall SE reports from Munich
Published on 06/18/2026 at 06:40, 1 hour 29 minutes ago

APES 2026: 2,000+ Chinese Source Factories, One-Stop Direct Sourcing -Maximizing Buyer Margins

Les Echos

Published on 06/18/2026 at 07:00, 1 hour 10 minutes ago

bioMérieux introduces Salmonella testing kit on GENE-UP® TYPER to support root cause analysis in the food industry
Published on 06/17/2026 at 17:40, 14 hours 30 minutes ago

Report on share repurchases from 10 to 16 June 2026
Published on 06/17/2026 at 08:45, 23 hours 25 minutes ago

Air Liquide is awarded its largest-ever contract in Spain to care for 90,000 patients living with respiratory conditions at home
Published on 06/16/2026 at 11:44, 1 day 20 hours ago

Guillemot Corporation S.A. | Weekly report share buyback from June 8 to June 12 2026
Published on 06/15/2026 at 23:00, 2 days 9 hours ago

BIOPHYTIS ANNOUNCES THE TEMPORARY SUSPENSION OF THE TRADING OF ITS SHARES

View all LES ECHOS COMFI WIRE